Polypeptide Group
Baar
About Polypeptide Group
The PolyPeptide Group is a contract manufacturing organization for peptides and peptide related molecules. A global presence throughout the world assures our clients a reliable supply with the necessary capacity for an uninterrupted service. The Group is one of the world’s largest independent contract manufacturers of therapeutic peptides for the cosmetic, pharmaceutical and veterinary markets employing more than 450 people in six manufacturing sites located in France, India, Scandinavia and the USA. PolyPeptide Group is privately-held organization that manufactures over one third of all approved peptide drug substances (22 of 62 approved products worldwide) accounting for over 25% of the sales of outsourced peptide therapeutics worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $100K – $500K
- Total funding: $161.8M
- Funding stage: IPO
- Last round: Post-IPO Debt (May 2025)
- Ticker: swx:PPGN
- Website: polypeptide.com
- Phone: +46 40 366 200
Industries & Categories
Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/polypeptide-group-72660 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.